American Heart Journal
Volume 156, Issue 3 , Pages 549-555 , September 2008

Angiotensin inhibition in renovascular disease: A population-based cohort study

  • Daniel G. Hackam, MD, PhD

      Affiliations

    • Division of Clinical Pharmacology, University of Western Ontario, London, Ontario, Canada
    • Corresponding Author InformationReprint requests: Daniel G. Hackam, Room 100K, Siebens Research Building 1400 Western Road, London, Ontario, Canada N6G 2V2.
    • ,
  • Minh L. Duong-Hua, MSc

      Affiliations

    • Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
    • ,
  • Muhammad Mamdani, PharmD, MA, MPH

      Affiliations

    • Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
    • Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Ping Li, PhD

      Affiliations

    • Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
    • ,
  • Sheldon W. Tobe, MD

      Affiliations

    • Division of Nephrology, University of Toronto, Toronto, Ontario, Canada
    • ,
  • J. David Spence, MD

      Affiliations

    • Division of Clinical Pharmacology, University of Western Ontario, London, Ontario, Canada
    • ,
  • Amit X. Garg, MD, PhD

      Affiliations

    • Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
    • Division of Nephrology, University of Western Ontario, London, Ontario, Canada

Received 28 January 2008 ,Accepted 6 May 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The study was supported by an unrestricted research grant from the University of Western Ontario, London, Ontario, Canada. None of the funding sources participated in the design or conduct of the research; collection, management, analysis, or interpretation of the data; or the preparation, review, and approval of the manuscript.

 No conflicts of interest exist for D.G.H., M.L.D., M.M., P.L., or A.X.G. J.D.S. has consulted for Novartis and received lecture fees from Solvay. SWT has participated in research studies, advisory panels, and lectures with support from AstraZeneca, Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Sanofi-Aventis, Merck, and Novartis.

PII: S0002-8703(08)00385-2

doi: 10.1016/j.ahj.2008.05.013

American Heart Journal
Volume 156, Issue 3 , Pages 549-555 , September 2008

Article Tools

* Image Usage & Resolution